Medicus Pharma Ltd. — Investor Relations & Filings
Filings indexed
262
across all filing types
Latest filing
2026-05-04
Annual Report
Country
CA
Canada
Listing
US
MDCX
Medicus Pharma Ltd. is a biotechnology and life sciences company focused on accelerating the clinical development of novel and disruptive therapeutic assets. The company's primary focus is on developing non-invasive treatments for dermatological conditions, specifically non-melanoma skin cancers. Its lead therapeutic candidate, SKNJCT-003, is being developed by its subsidiary, SkinJect Inc., for the treatment of basal cell carcinoma (BCC). The candidate is currently in Phase 2 clinical studies. Medicus Pharma aims to deliver improved treatment outcomes through the development of first-in-class and best-in-class therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Medicus Pharma Ltd. (0001997296) (Filer) | 2026-05-04 | English | |
| 10-K/A - Medicus Pharma Ltd. (0001997296) (Filer) | 2026-04-29 | English | |
| 8-K - Medicus Pharma Ltd. (0001997296) (Filer) | 2026-04-24 | English | |
| EFFECT - Medicus Pharma Ltd. (0001997296) (Filer) | 2026-03-30 | English | |
| EFFECT - Medicus Pharma Ltd. (0001997296) (Filer) | 2026-03-30 | English | |
| EFFECT - Medicus Pharma Ltd. (0001997296) (Filer) | 2026-03-30 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 41052845 | ARS - Medicus Pharma Ltd. (0001997296) (Filer) | 2026-05-04 | English | ||
| 38833876 | 10-K/A - Medicus Pharma Ltd. (0001997296) (Filer) | 2026-04-29 | English | ||
| 36290432 | 8-K - Medicus Pharma Ltd. (0001997296) (Filer) | 2026-04-24 | English | ||
| 33086612 | EFFECT - Medicus Pharma Ltd. (0001997296) (Filer) | 2026-03-30 | English | ||
| 33086613 | EFFECT - Medicus Pharma Ltd. (0001997296) (Filer) | 2026-03-30 | English | ||
| 33086620 | EFFECT - Medicus Pharma Ltd. (0001997296) (Filer) | 2026-03-30 | English | ||
| 33043039 | POS AM - Medicus Pharma Ltd. (0001997296) (Filer) | 2026-03-25 | English | ||
| 32286969 | S-3 Filing | 2026-01-30 | English | ||
| 13675378 | Major Shareholding Notification 2026 | 2026-01-06 | English | ||
| 13675380 | FORM 424B5 | 2026-01-02 | English | ||
| 13675381 | Regulatory Filings 2026 | 2026-01-02 | English | ||
|
2025
4 filings
| |||||
| 13675382 | FORM 424B3 | 2025-12-30 | English | ||
| 13675383 | FORM 424B3 | 2025-12-30 | English | ||
| 13675384 | FORM 424B3 | 2025-12-30 | English | ||
| 13675385 | FORM 424B3 | 2025-12-30 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Anika Therapeutics, Inc.
A global joint preservation company developing solutions fo…
|
ANIK | US | Manufacturing |
|
ANIMALCARE GROUP PLC
Develops and commercializes veterinary pharmaceutical produ…
|
ANCR | GB | Manufacturing |
|
ANI PHARMACEUTICALS INC
Develops, manufactures, and markets branded, generic, and O…
|
ANIP | US | Manufacturing |
|
ANLON HEALTHCARE LIMITED
Researches and manufactures APIs, intermediates, and finish…
|
AHCL | IN | Manufacturing |
|
Annexin Pharmaceuticals AB
Clinical-stage biotech developing a cell-protecting biologi…
|
ANNX | SE | Manufacturing |
|
Annexon, Inc.
Clinical-stage biopharma developing complement medicines by…
|
ANNX | US | Manufacturing |
|
Antengene Corporation Limited
Global biopharma developing and commercializing novel oncol…
|
6996 | KY | Manufacturing |
|
ANTEROGEN CO., LTD.
Develops and commercializes cell therapies and orphan drugs…
|
065660 | KR | Manufacturing |
|
Antibiotice S.A.
Pharmaceutical firm manufacturing generic medicines, anti-i…
|
ATB | RO | Manufacturing |
|
Anuh Pharma Ltd.
Manufacturer of APIs and bulk drugs specializing in Macroli…
|
ANUHPHR | IN | Manufacturing |
Medicus Pharma Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34562/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34562 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34562 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34562 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34562}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Medicus Pharma Ltd. (id: 34562)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.